+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
ID06068023

ADAPTA Study Adjuvant Chemotherapy After Surgery for Ampullary Adenocarcinoma Tailored Treatment by Cancer Subtype to Improve Survival

Led by Fondazione Poliambulanza Istituto Ospedaliero · Updated on 2023-10-05

400

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Ampullary adenocarcinoma AAC is a rare type of gastrointestinal cancer with different survival rates depending on its subtype, especially the aggressive pancreatobiliary PB subtype. This research aims to study tailored adjuvant chemotherapy treatments based on the cancers histopathology to improve survival outcomes. The study is a phase II prospective single-arm multicenter cohort trial enrolling 200 patients with resected AAC, split evenly between intestinal and PBmixed subtypes. Participants with intestinal subtype AAC will receive CAPOX chemotherapy cycles every 3 weeks, while those with PB and mixed subtypes will receive modified FOLFIRINOX chemotherapy every 2 weeks for 8 to 12 cycles. The study compares outcomes with patients not treated according to this regimen from participating centers. Both groups include patients willing and unwilling to receive adjuvant chemotherapy due to logistics or preference. During the study, participants will be monitored for up to 5 years with evaluations including disease-free survival at 3 and 5 years, overall survival, and quality of life questionnaires. Researchers will collect clinical data to assess treatment effects and follow participants after surgery and chemotherapy to evaluate safety and long-term outcomes. The total participation duration varies depending on follow-up and assessment schedules.

CONDITIONS

Brief Title

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Research Team

M

Moh'd Abu Hilal, MD, PhD

B

Bas Uijterwijk

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here